Abattis Bioceuticals Corp.
ATTBF · OTC
9/30/2019 | 6/30/2019 | 3/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$926 | -$736 | -$143 | -$1,257 |
| Dep. & Amort. | $46 | $21 | $21 | $20 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $2 |
| Change in WC | -$147 | $8,215 | $409 | -$29 |
| Other Non-Cash | $4,962 | -$2 | -$877 | -$168 |
| Operating Cash Flow | $3,935 | $7,498 | -$590 | -$1,431 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$5,037 | -$2 | -$17 | -$5 |
| Net Acquisitions | -$9,851 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$8,321 | -$1,480 | -$50 |
| Inv. Sales/Matur. | $431 | -$151 | $0 | $0 |
| Other Inv. Act. | $4,851 | $0 | $3,115 | $0 |
| Investing Cash Flow | -$4,606 | -$8,474 | $1,618 | -$55 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | -$60 | $60 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $60 | $0 |
| Financing Cash Flow | $0 | $0 | $0 | $60 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$671 | -$975 | $1,028 | -$1,426 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,690 | $3,665 | $2,638 | $4,064 |
| End Cash | $2,019 | $2,690 | $3,665 | $2,638 |
| Free Cash Flow | -$1,102 | $7,497 | -$607 | -$1,436 |